CAAP Company: MyndTec Announces 510(k) Clearance for MyndMove® Therapy for Individuals with Upper Extremity Paralysis

MyndTec, an award-winning Canadian medical technology company announced today it has received 510(k) clearance to market its landmark product MyndMove®.  MyndTec is a pioneer in the treatment of arm and hand paralysis caused by stroke or spinal cord injury. 

This is a major milestone in the evolution of our company. We are delighted that we can now offer this life-changing therapy to patients in the U.S. with upper extremity paralysis.
— Dr. Milos R. Popovic, MyndTec Founder

For the full press release click here

Previous
Previous

Synaptive Medical Honoured in Fast Company’s Innovation By Design Awards

Next
Next

CAAP Companies: Komodo OpenLab & KE2 Technologies Advance to the Top 10 in the Interface Health Challenge